AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report
· nypost.com
UK drugmaker AstraZeneca has been exploring a deal to combine with US rival Bristol Myers Squibb, the Financial Times reported on Sunday, citing people familiar with the matter.
See more of our coverage in your search results.
UK drugmaker AstraZeneca has been exploring a deal to combine with US rival Bristol Myers Squibb, the Financia...